期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多囊卵巢综合征患者子宫内膜非典型增生的研究进展

Research progress of atypical andometrial hyperplasia in patients with polycystic ovary syndrome
下载PDF
导出
摘要 多囊卵巢综合征(polycystic ovary syndrome,PCOS)是与女性生殖和代谢相关的常见内分泌障碍性疾病,各种内分泌激素通过子宫内膜受体或(和)受体结合发挥作用,使PCOS患者子宫内膜可能表现为分泌期反应不良、单纯性增生、复杂性增生、不典型性增生甚至癌变等。PCOS对子宫内膜的影响机理的研究是国外近年研究的热点之一。 The polycystic ovary syndrome （PCOS） is a familiar endocrine obstacle disease which related to female reproduction and metabolism. Various endocrine hormone which interacted with or/and combined with endometrial receptors may make the endometrimn of patients with PCOS manifested as abnormal secretory phase, simple endo- metrial hyperphasia, complex ＇endometrial hyperphasia, atypical endometrial hypcrplasia, even adenocarcinoma. The research on the effect mechanism of PCOS on endometrium is a hot spot of study at abroad in recent years.
作者 刘妮平 潘海花 马刚
机构地区 广西壮族自治区人民医院妇产科
出处 《中国临床新医学》 2011年第1期88-90,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 多囊卵巢综合征 子宫内膜非典型增生 Polycystic ovary syndrome（PCOS） Atypical endometrial hyperplasia
分类号 R711.75 [医药卫生—妇产科学]
  • 相关文献

参考文献13

  • 1Lane DE. Folycystic ovary syndrome and its dfferential diagnosis [ J]. Obstet Gynecol Surv,2006,61 (2) :125 - 135.
  • 2Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer [J]. Semin Reprod Med,2008,26 (1) :62 - 71.
  • 3Leon L, Bacallao K, Gabler F, et al. Activities of steroid metabolic enzymes in secrelory endometria from untreated women with Polycystic Ovary Syndrome[ J]. Steroids,2008,73 ( 1 ) :88 - 95.
  • 4LaZovie G, Radivojevic U, Milieevic S, et al. Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients [ J ]. Int J Fertil Womens Med, 2007,52 ( 2 - 3 ) : 82 - 88.
  • 5Sharma D, Saxena NK, Vertino PM. Ieptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways [ J ]. Endocr Relat Cancer,2006,13(2) :629 -640.
  • 6Villavicencio A, Bacallao K. Gabler F, et al. Deregulation of tissue homeostasis in endometia from patients with polycystic ovarian syndrome with and without endometrial hyperplasia [ J ]. Gynecol Oncol, 2007, 104(2) :290 -295.
  • 7Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J].Fertil 5teril,2002,77(6) :1095 -1105.
  • 8Iatrakis G, Tsionis C. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium [ J ]. Eur J Obstet Gyneeol Reprod Biol,2006,127(2) :218 -221.
  • 9Kacalska O, Krzyezkowska-Sendrakowska M, Milewiez T, et al. Molecularaction of insulin-sensitizing agents [ J ]. Endokrynol Pol, 2005,56 (3) :308 -313.
  • 10Berstein LM, Kvatchevskaya JO, Poroshina TE. Insulin resistance, its consequences for the clinical course of the disease, and possthilities of correction in endometrial cancer [ J ]. J Cancer Res Clin Oncol, 2004,130( 11 ) :687 -693.

二级参考文献16

  • 1乔杰,陈咏健,朱馥丽,杨池荪,毛文伟.多囊卵巢综合征血浆瘦素的改变及相关影响因素的研究[J].中国妇产科临床杂志,2002,3(3):156-158. 被引量：4
  • 2Elter K,Imir G,Durmusoglu F.Clinical,endocrine and metabolic effects of metforrnin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study [J].Hum Reprod,2002,17(7):1729-1737.
  • 3Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population[J]. J Clin Endocrinol Metab,2004, 89:2745-2749.
  • 4Carmina E. Dignosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines[J] . Minerva Ginecol,2004,56(1):126.
  • 5Vvbikova J, Dvoria K. Determinants of circulating adiponectin in women with polycystic ovary syndrome[J].Gynecol Obstet Invest,2005,60(3):155-161.
  • 6Gemignani ML, Hensley ML, Cohen R, et al. Paclitaxel based chemotherapy in carcinoma of the fallopian tube[J]. Gynecol Oncol, 2001,80(1):16-20.
  • 7Wagenaar HC, Pecorelli S, Vergote I, et al. Phase II study of a combination of cyclophosphamide, sadriamycinand cisplatin in advanced fallopian tube carcinoma:an EORTC gynecological cancer group study[J].Eur J Gynecol Oncol, 2001,22(3):187-193.
  • 8Kolodziejeczyk B, Duleba AJ, Spaczynski RZ, et al. Metformin therapy decreases hyperandrogenism and hyperinsulinaemia in women with poly cystic ovary syndrome[J] . Fertil Steril,2000,73(6):1149-1154.
  • 9Loverro G, Lorusso F, De Pergola G, et al. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome[J] . Gynecol Endocrinol,2002,16(3):217-224.
  • 10Stadtmauer LA, Wong BC, Oehninger S. Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome-beyond ovulation induction[J] . Hum Reprod, 2002,17(12):3016-3025.

共引文献23

中国临床新医学
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部